Title Credit Typesort descending Event date Cost
Management of Acute Myeloid Leukemia in 2020: A Paradigm Shift for Older Adults? SPOC
    • 1.00 Participation
 Enduring $0.00
Acute Radiation Side Effects - SPOC
    • 1.00 Participation
 Enduring $0.00
Common Considerations in Caring for Patients with Cancer
    • 1.00 Participation
 Enduring $0.00
Lung Cancer Management in North Carolina: Updates for 2020 - SPOC
    • 1.00 Participation
 Enduring $0.00
Dos, Don’ts, and the Basics of Providing Care to Patients Experiencing Intimate Partner Violence
    • 1.00 ACPE Pharmacist
    • 1.00 ACPE Pharmacy Tech
    • 1.00 ASRT
    • 1.00 NCPD/CNE
    • 1.00 Participation
 Enduring $0.00
Building Cancer Care Collaboratives for the Seventh Generation - SPOC
    • 1.00 Participation
 Enduring $0.00
Navigating Serious Illness with Palliative Care and Hospice
    • 1.00 ACPE Pharmacist
    • 1.00 ACPE Pharmacy Tech
    • 1.00 AMA PRA Category 1 Credit™
    • 1.50 ASRT
    • 1.00 CTR
    • 1.00 NCPD/CNE
    • 1.00 Participation
 Enduring $0.00
Improving Recognition and Treatment of Cognitive Problems in Cancer
    • 1.00 ACPE Pharmacist
    • 1.00 ACPE Pharmacy Tech
    • 1.00 ASRT
    • 1.00 CTR
    • 1.00 NCPD/CNE
    • 1.00 Participation
 Enduring $0.00
APPs Role in Cancer Survivorship Care SPOC
    • 1.00 Participation
 Enduring $0.00
Oncologic Emergencies: Superior Vena Cava Syndrome, Hypercalcemia, and SIADH
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 NCPD/CNE
    • 1.00 Participation
 Enduring $0.00
Sex and AYAs with Cancer: Mitigating Risk and Managing Sexual Dysfunction - SPOC
    • 1.00 Participation
 Enduring $0.00
Primary Brain Tumors: Diagnosis and Management Strategies - SPOC
    • 1.00 ACPE Pharmacist
    • 1.00 ACPE Pharmacy Tech
    • 1.00 AMA PRA Category 1 Credit™
    • 1.25 ASRT
    • 1.00 CTR
    • 1.00 NCPD/CNE
    • 1.00 Participation
 Enduring $0.00
Immune (check point) Related Adverse Events 2021 SPOC
    • 1.00 Participation
 Enduring $0.00
Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC): An Evolving Diagnostic and Therapeutic Paradigm
    • 1.00 ACPE Pharmacist
    • 1.00 ACPE Pharmacy Tech
    • 1.00 CTR Category A
    • 1.00 NCPD/CNE
    • 1.00 Participation
 Enduring $0.00
Prostate Cancer Management in North Carolina: Updates for 2020 SPOC
    • 1.00 Participation
 Enduring $0.00

Pages